Sales and Marketing

Showing 15 posts of 11520 posts found.

Roche scores FDA approval for Polivy combo in diffuse large B-cell lymphoma

June 11, 2019 Manufacturing and Production, Sales and Marketing Polivy, Roche, lymphoma, pharma

Roche is celebrating the decision taken by the FDA to approve its anti-CD79b antibody-drug conjugate Polivy (polatuzumab vedotin-piiq) in combination …
paul-hudson-big-image

Novartis Pharma head to become new Sanofi CEO

June 10, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Paul Hudson, appointment, olivier brandicourt

French drugmaker Sanofi has revealed that its CEO Olivier Brandicourt is to retire from the role, to be replaced with …
shutterstock_273326141

MSD scoops up biopharma firm Tilos for $773 million

June 10, 2019 Sales and Marketing MSD, Tilos Therapeutics, acquisition, pharma

US-based firm MSD has announced it intends to acquire biopharma firm Tilos Therapeutics, and has signed a deal with the …

Sanofi’s Soliqua proves superior to GLP-1 RA therapies in reducing blood sugar levels

June 10, 2019 Research and Development, Sales and Marketing Sanofi, Soliqua, diabetes, pharma, type 2 diabetes

Sanofi has stepped up at the American Diabetes Association (ADA) 79th Scientific Sessions in San Francisco, revealing new data which …

Novo’s oral semaglutide tops Jardiance and Victoza in two type 2 diabetes trials

June 10, 2019 Research and Development, Sales and Marketing Novo Nordisk, diabetes, pharma, semaglutide, type 2 diabetes

Novo Nordisk has taken the opportunity at the American Diabetes Association (ADA) 79th Scientific Sessions to pull back the curtain …
fda2outsideweb

FDA advisory panel backs TB Alliance’s tuberculosis regimen

June 10, 2019 Sales and Marketing FDA, TB Alliance, US, pharma, tuberculosis

An FDA advisory panel has voted to recommend the investigational drug pretomanid, developed by the non-profit organisation TB Alliance, as …
ward_lilley

Vectura CEO to step down at end of June

June 10, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, pharma, vectura

Vectura is on course for a new leader to take up the company’s reins after it was revealed that CEO …

Implementing “the safest medicines system in the world”

June 10, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing feature, packaging, pharma

With debates heating up over cooperation between European across the continent, Matt Fellows investigates the current state of packaging countermeasures …
mercier

Long-term BMS exec Johanna Mercier joins Gilead as new Chief Commercial Officer

June 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, appointment, pharma

Gilead Sciences have said Bristol-Myers Squibb exec Johanna Mercier will be the firm’s new Chief Commercial Officer. In her new …
paul-hudson-big-image

Novartis Pharma head to become new Sanofi CEO

June 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Paul Hudson, Sanofi, appointment, olivier brandicourt, pharma

French drugmaker Sanofi has revealed that its CEO Olivier Brandicourt is to retire from the role, to be replaced with …
marie-france_tschudin

Marie-France Tschudin, head of Novartis subsidiary AAA, takes over from Paul Hudson as Novartis Pharma CEO

June 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Novartis has said Marie-France Tschudin will take over from Paul Hudson as the head of Novartis Pharmaceuticals. The announcement comes …
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

June 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen, EMA, Janssen, Orkambi, Pfizer

It was revealed this week that Pfizer suppressed findings that their anti-inflammatory Enbrel reduced the risk of Alzheimer’s by 64%. …
shutterstock_204190579

Healthcare communications: Time to think differently with patient centricity

June 6, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, Spink, UK, patient centricity, pharma

Patient centricity, derived from the NHS-driven thinking “no decision about me, without me,” has been adopted by pharma to understand …

Pfizer recruits new Group Head of Oncology R&D

June 6, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Pfizer has said Dr Jeff Settleman will join the firm as the company’s new Senior Vice President and Group Head …

Battling cervical cancer in the developing world

June 6, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Doctors Without Borders, Medecins sans frontieres; cancer, cervical cancer, malawi, pharma

The non-profit humanitarian organization Medecins Sans Frontieres, or Doctors Without Borders, is well known for its work fighting on the …
The Gateway to Local Adoption Series

Latest content